Abbott LaboratoriesABT +3.49%76 14-Day RSI is 62.71 as of Jul. 05, 2026. GuruFocus rates ABT with a GF Score™ of 76/100 and a GF Value™ of $129.98 (Modestly Undervalued). Among 870 Medical Devices & Instruments companies, Abbott Laboratories ranks worse than 86.32% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Abbott Laboratories 14-Day RSI Related Terms
ABT vs SYK, MDT, BSX: 14-Day RSI Comparison
For the Medical Devices subindustry, Abbott Laboratories's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott Laboratories 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories (ABT) has a 14-Day RSI of 62.71 as of Jul. 05, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Abbott Laboratories and its competitors. According to the industry distribution chart, Abbott Laboratories ranks #751 out of 870 companies in the Medical Devices & Instruments industry, placing it in the top 86.3%.
Is Abbott Laboratories' 14-Day RSI too high?
Abbott Laboratories' current 14-Day RSI is 62.71. The Medical Devices & Instruments industry median 14-Day RSI is 49.50. Abbott Laboratories' value of 62.71 is 26.7% above this industry median. Based on the distribution chart, Abbott Laboratories ranks #751 out of 870 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Abbott Laboratories has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' 14-Day RSI compare to SYK and MDT?
According to the Medical Devices & Instruments industry distribution chart, Abbott Laboratories ranks #751 out of 870 companies for 14-Day RSI. This places Abbott Laboratories in the lower half of its industry. The industry median 14-Day RSI is 49.50. Abbott Laboratories' value of 62.71 is 26.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 49.50, based on 870 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abbott Laboratories's current 14-Day RSI of 62.71 is 26.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Abbott Laboratories and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 49.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abbott Laboratories's current 14-Day RSI is 62.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (ABT) is currently considered Modestly Undervalued. The stock's GF Value™ is $129.98, compared to a current price of $95.40 — trading 26.6% below its estimated fair value. The current 14-Day RSI is 62.71 and 26.7% above the Medical Devices & Instruments industry median of 49.50. Abbott Laboratories' overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Abbott Laboratories (ABT), the current 14-Day RSI is 62.71 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abbott Laboratories (ABT) Overvalued in 2026?
Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued.
The current stock price of $95.40 is trading 26.6% below its estimated GF Value™ of $129.98.
GuruFocus considers Abbott Laboratories to be Modestly Undervalued.
Key valuation signals for ABT:
14-Day RSI: 62.71
GF Value™: $129.98 vs. price of $95.40 (26.6% below fair value)
Industry Position: 26.7% above the Medical Devices & Instruments median (#751 of 870)
No single metric tells the full story. See the ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
76GF Score
Get the complete analysis for ABT
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ABT has been successfully added to your 